Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance

Diabetes

Volumn 43, Issue 2, 1994, Pages 247-255

  Moller, David E ^a   Cohen, Ohad ^a   Yamaguchi, Yoshihiko ^a   Assiz, Ricardo ^b   Grigorescu, Florin ^c   Eberle, Andrea ^d   Morrow, Linda A ^a   Moses, Alan C ^a   Flier, Jeffrey S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c INSERM   (France)

^d UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HYPERANDROGENISM; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0028044901     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.2.247     Document Type: Article

References (65)

1. Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, De La Luz Sierra M, Suzuki Y, Koller E, Levy-Toledano R, Wertheimer E, Moncada VY, Kadowaki H, Kadowaki T: Mutations in the insulin receptor gene. Endocr Rev 13:566-95, 1992
2. O'Rahilly S, Moller DE: Mutant insulin receptors in syndromes of insulin resistance. Clin Endocrinol 36:121-32, 1992
3. Elsas LJ, Endo F, Strumlauf E, Elders J, Priest JH: Leprechaunism: an inherited defect in a high-affinity insulin receptor. Am J Hum Genet 37:73-88, 1985
4. Elsas LJ, Endo F, Priest JH, Strumlauf E: Leprechaunism: an inherited defect in insulin-receptor interaction. In Congenital Metabolic Disease: Diagnosis and Treatment. Wapnir RA, Ed. New York, Marcel Dekker, 1985, p. 301
5. Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, Imura H, Bell GI, Steiner DF: Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 240:784-87, 1988
6. Kadowaki T, Kadowaki H, Rechler MM, Serrano-Rios M, Roth J, Gorden P, Taylor SI: Five mutant alletes of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest 86:254-64, 1990
7. West RJ, Lloyd JK, Turner WML: Familial insulin-resistant diabetes, multiple somatic anomalies, and pineal hyperplasia. Arch Dis Child 50:703-708, 1975
8. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin NM, Roth J: The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N Engl J Med 294:739-45, 1976
9. Moller DE, Flier JS: Insulin resistance: mechanisms, syndromes, and implications. N Engl J Med 325:938-48, 1991
10. Barbieri RL, Ryan KJ: Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 147:90-101, 1983
11. Flier JS, Kahn CR, Roth J, Bar RS: Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63-65, 1975
12. Dunaif A, Hoffman AR, Scully RE, Flier JS, Longcope C, Levy LJ, Crowley WF: Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans. Obstet Gynecol 66:545-52, 1985
13. Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW: Acanthosis nigricans in obese women with hyperandrogenism: characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes 34:101-107, 1985
14. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A: Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65:499-507, 1987
15. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L: Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab 73:590-95, 1991
16. Cama A, Sierra ML, Ottini L, Kadowaki T, Gorden P, Imperato-McGinley J, Taylor SI: A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab 73:894-901, 1991
17. Kim H, Kadowaki H, Sakura H, Odawara M, Momomura K, Takahashi Y, Miyazaki Y, Ohtani T, Akanuma Y, Yazaki Y, Kasuga M, Taylor SI, Kadowaki T: Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms. Diabetologia 35:261-66, 1992
18. Accili D, Frapier C, Mosthaf L, McKeon C, Elbein SC, Permutt MA, Ramos E, Lander E, Ullrich A, Taylor SI: A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes, EMBO J 8:2509-17, 1989
19. Shimada F, Taira M, Suzuki Y, Hashimoto N, Nozaki O, Tatibana M, Ebina Y, Tawata M, Onaya T, Makino H, Yoshida S: Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene. Lancet 335:1179-81, 1990
20. Moller DE, Flier JS: Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and polycystic ovary syndrome (type A insulin resistance). N Engl J Med 319:1526-29, 1988
21. Moller DE, Yokota A, White MF, Pazianos AG, Flier JS: A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem 265:14979-85, 1990
22. Kusari J, Takata Y, Hatada E, Freidenberg G, Kolterman O, Olefsky JM: Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. J Biol Chem 266:5260-67, 1991
23. Taira M, Hasimoto N, Shimada F, Suzuki Y, Kanatsuka A, Nakamura F, Ebina Y, Tatibana M, Makino H, Yoshida S: Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science 245:63-66, 1989
24. American Diabetes Association: Position Statement: Office guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care 15 (Suppl. 2):4, 1992
25. Plourde PV, Marks JG, Hammond JM: Acanthosis nigricans and insulin resistance. J Am Acad Dermatol 10:887-91, 1984
26. Rendon MI, Cruz PD, Sontheimer RD, Bergstresser PR: Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol 21:461-69, 1989
27. Seip M, Trygstad O: Generalized lipodystrophy. Arch Dis Child 38:447, 1963
28. Seip M: Generalized lipodystrophy. In Results of Internal Medicine and Pediatrics (In German). Heidelberg, Springer-Verlag 1971, Vol. XXXI, p. 59-69
29. Oseid S: Studies in congenital generalized lipodystrophy (Seip-Berardinelli syndrome). I. Development of diabetes. Acta Endocrinol 72:475-94, 1973
30. Moller DE, O'Rahilly S: Congenital syndromes of severe insulin resistance. In Insulin Resistance. Moller DE, Ed. Chichester, Wiley, 1993
31. Hatch R, Rosenfield RL, Kim MH, Tredway D: Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815-30, 1981
32. Flier JS, Young JB, Landsberg L: Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps: a new syndrome. N Engl J Med 390:970-73, 1980
33. Low L, Chernausek SD, Sperling MA: Acromegaloid patients with type A insulin resistance: parallel defects in insulin and insulin-like growth factor-I receptors and biological responses in cultured fibroblasts. J Clin Endocrinol Metab 69:329-37, 1989
34. Flier JS, Moller DE, Moses AC, O'Rahilly S, Chaiken R, Grigorescu F, Kahn BB, Weinreb JE, Eastman R: Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 76:1533-41, 1993
35. Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YD, Reaven GM: Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66:580-83, 1988
36. Ausubel FM, Brent R, Kingston RE: Current Protocols in Molecular Biology. New York, Wiley, 1987
37. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-61, 1985
38. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-94, 1988
39. Choi WH, O'Rahilly S, Buse JB, Rees A, Morgan R, Flier JS, Moller DE: Molecular scanning of the insulin-responsive glucose transporter (GLUT4) gene in patients with non-insulin-dependent diabetes mellitus. Diabetes 40:1712-18, 1991
40. Moller DE, Yokota A, Flier JS: Normal insulin receptor cDNA sequence in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetes 38:1496-1500, 1989
41. Seino S, Seino M, Bell GI: Human insulin-receptor gene: partial sequence and amplification of exons by polymerase chain reaction. Diabetes 39:123-28, 1990
42. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-79, 1989
43. Hitman GA, Karir PK, Mohan V, Rao PV, Kohner EM, Levy JC, Mather H: A genetic analysis of type II (non-insulin-dependent) diabetes mellitus in Punjabi Sikhs and British Caucasoid patients. Diabet Med 4:526-30, 1987
44. O'Rahilly S, Choi WH, Patel P, Turner RC, Flier JS, Moller DE: Detection of mutations in the insulin receptor gene in non-insulin-dependent diabetic patients by analysis of single-stranded conformation polymorphisms. Diabetes 40:777-82, 1991
45. Seino S, Seine M, Nishi S, Bell GI: Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 86:114-18, 1989
46. O'Rahilly S, Krook A, Bishop A, Rees A, Flier JS, Moller DE: Insulin receptor and insulin-responsive glucose transporter (GLUT4) mutations and polymorphisms in a Welsh non-insulin-dependent diabetic population. Diabetologia 35:486-89, 1992
47. Schwenk WF, Rizza RA, Mandarino LJ, Gerich JE, Hayles AB, Haymond MW: Familial insulin resistance and acanthosis nigricans: presence of a postbinding defect. Diabetes 35:33-37, 1986
48. Scarlett JA, Kolterman OG, Moore P, Saekow M, Insel J, Griffin J, Mako M, Rubenstein AH, Olefsky JM: Insulin resistance and diabetes due to a genetic defect in insulin receptors. J Clin Endocrinol Metab 55:123-31, 1982
49. Rudiger HW, Dreyer M, Kuhnau J, Bartelheimer H: Familial insulin-resistant diabetes secondary to an affinity defect of the insulin receptor. Hum Genet 64:407-11, 1983
50. Odawara M, Kadowaki T, Yamamoto R, Shibasaki Y, Tobe K, Accili D, Bevins CL, Mikami Y, Matsuma N, Akanuma Y, Takaku F, Taylor SI, Kasuga M: Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science 245:66-68, 1989
51. Stuart CA, Pietrzyk RA, Peters EJ, Smith FE, Prince MJ: Autophosphorylation of cultured skin fibroblast insulin receptors from patients with severe insulin resistance and acanthosis nigricans. Diabetes 38:328-32, 1989
52. Dunaif A: Insulin resistance and ovarian dysfunction. In Insulin Resistance. Moller DE, Ed. Chichester, Wiley, 1993
53. Dunaif A, Givens JR, Haseltine FP, Merriam GR: The Polycystic Ovary Syndrome. Cambridge, MA, Blackwell Scientific, 1992
54. Peters EJ, Stuart CA, Prince MJ: Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. Metabolism 35:807-13, 1986
55. Oseid S, Beck-Nielsen H, Pedersen O, Sovik O: Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 296:245-48, 1977
56. Wachslicht-Rodbard H, Muggeo M, Kahn CR, Saviolakis GA, Harrison LC, Flier JS: Heterogeneity of the insulin-receptor interaction in lipoatropic diabetes. J Clin Endocrinol Metab 52:416-25, 1981
57. Magre J, Reynet C, Capeau J, Blivet MJ, Picard J: In vitro studies of insulin resistance in patients with lipoatrophic diabetes: evidence for heterogeneous postbinding defects. Diabetes 37:421-82, 1988
58. Magre J, Grigorescu F, Reynet C, Caron M, Capony JP, White MF, Picard J, Mirouze J, Capeau J: Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatropic diabetes. J Clin Endocrinol Metab 69:142-50, 1989
59. Hunter T, Cooper JA: Viral oncogenes and tyrosine phosphorylation. In The Enzymes. Boyer PD, Ed. Orlando, Academic, 1986, p. 1991
60. Flores-Riveros JR, Sibley E, Kastelic T, Lane D: Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. J Biol Chem 264:21557-72, 1989
61. Goldstein BJ, Dudley AL: The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. Mol Endocrinol 4:235-44, 1990
62. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, LeBon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y: Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-12, 1986
63. Moritz W, Boni-Schnetzler M, Froesch ER: Functional characterisation of insulin receptors of four type A insulin resistant patients. In Program and Abstracts of 75th Annual Meeting of the Endocrine Society, 1993, Las Vegas, NV 1507A, p. 427
64. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-66, 1992
65. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC: Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 75:577-83, 1992